Clinical trial
PINNACLE I Clinical Study: a Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter for Treatment of Moderately to Severely Calcified, Stenotic De Novo Coronary Artery Lesions
NCT05828173 is registered in ClinicalTrials.gov with Elixir Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PINNACLE I Clinical Study: a Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter for Treatment of Moderately to Severely Calcified, Stenotic De Novo Coronary Artery Lesions
- Lead sponsor
- Elixir Medical Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2023
- Completion date
- September 9, 2024
- Enrollment
- 60 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.